SPOTLIGHT: VCs back Caprotec

Berlin-based startup Caprotec Bioanalytics GmbH has rounded up $8.8 million in two rounds of financing from Creathor Venture, IBB Beteiligungsgesellschaft, ERP Startfonds and private investors for further development and marketing of its platform technology for analyzing complex protein mixtures. Release

Suggested Articles

More than half of the participants met the primary endpoint, teeing Sanofi up to file for FDA approval of the complement C1s inhibitor.

Cellarity is combining artificial intelligence, a protein discovery platform and what it calls “network biology” in a new drug discovery approach.

Bluebird bio offered the first glimpse of how its CAR-T follow-up is working in multiple myeloma patients who have tried several other treatments.